J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.81 CNY 1.4% Market Closed
Market Cap: 25.7B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Net Margin
Jafron Biomedical Co Ltd

29.6%
Current
35%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
29.6%
=
Net Income
711.5m
/
Revenue
2.4B

Net Margin Across Competitors

Country CN
Market Cap 25.7B CNY
Net Margin
30%
Country US
Market Cap 204.7B USD
Net Margin
14%
Country US
Market Cap 180.7B USD
Net Margin
29%
Country US
Market Cap 139.9B USD
Net Margin
16%
Country US
Market Cap 124.8B USD
Net Margin
11%
Country IE
Market Cap 114.5B USD
Net Margin
12%
Country US
Market Cap 67.7B USD
Net Margin
7%
Country DE
Market Cap 53.6B EUR
Net Margin
8%
Country CN
Market Cap 338.5B CNY
Net Margin
34%
Country US
Market Cap 40B USD
Net Margin
74%
Country US
Market Cap 39.7B USD
Net Margin
9%

Profitability Report

View the profitability report to see the full profitability analysis for Jafron Biomedical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
29.6%
=
Net Income
711.5m
/
Revenue
2.4B
What is the Net Margin of Jafron Biomedical Co Ltd?

Based on Jafron Biomedical Co Ltd's most recent financial statements, the company has Net Margin of 29.6%.